Pan-European French nursing home group Colisée has become so overburdened by its debt that its creditors have insisted on taking control from private equity firm EQT, who has owned it since 2020.
Private equity firm CapVest will continue to be the majority shareholder of Curium Pharma, the world’s largest pure play nuclear medicine producer, for another three-to-five-year investment round. The company is being moved to a continuation vehicle in a recapitalisation deal that values it at around $7 billion.
Romania’s Competition Council has raised concerns about multinational Finnish outpatient group Mehilainen’s acquisition of Romania’s largest private healthcare group, Regina Maria.
German multinational medtech firm Siemens Healthineers is reviewing strategic options for its diagnostics division, including a possible sale. The company stated that its laboratory unit, which supplies a range of technologies to diagnostic labs including equipment and reagents, is being developed under several scenarios and may no longer be the best fit within the group.
UK-based listed digital mental healthcare group Kooth is continuing its expansion into the US market with the acquisition of Kismet, a small US digital mental healthcare company that specialises in under 12s. Kooth’s CEO Kate Newhouse tells us the acquisition will expand the capabilities and reach of Kooth’s US platform Soluna.
European Dental Group (EDG), Europe’s second largest dental group by revenue, has bought Fresh Tandartsen, a 41-clinic competitor in its home market of the Netherlands.
Vital Healthcare Property Trust, a listed New Zealand-based healthcare real estate investor, has bought back (internalised) its management rights from Canada-based Northwest Healthcare REIT (one of the world’s largest hospital-focused REITs), generating NZ$214 Million (~$170 million USD) for Northwest.
US healthcare REIT Welltower has acquired two medium-sized UK care home groups as part of its several-billion-pound investment into the UK’s care sector: it has acquired both the opco and the propco of Aria Care and Danforth Care.
France’s competition authority (Autorité de la concurrence) has issued a €4.7 million fine to telehealth platform Doctolib for using exclusivity clauses and for ‘predatory acquisition’ of a rival platform, MonDocteur, in 2018.
Two of Europe’s three largest private oncology groups are being merged into a single entity, creating continental Europe’s largest oncology player. Private equity firm Fremman Capital has acquired Stingray, an oncology group with a presence in France and Germany, to merge it with its portfolio company Amethyst, a major pan-European radiotherapy group which already has a presence in seven European countries.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
